Work

Initial results from BEACON, a phase 1b/2a dose escalation study of the anti-c-Kit briquilimab antibody in adults with chronic spontaneous urticaria (CSU)

Year: 2025

Type: article

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2024.12.998

Authors: Thomas Casale, Edwin Tucker, Jinwei Yuan, Daniel Adelman, David Ku, Annette Marcantonio, Patricia Carlos, Sophia Majeed, Wendy Pang, Marcus Maurer, Martin Metz

Institutions: University of South Florida, University of California, San Francisco, Charité – Universitätsmedizin Berlin

Language: English

Topic: Urticaria and Related Conditions

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4407340953

FWCI: 3.663

Cites:

Cited by: 5

Related to: 10